Establishment and characterization of gastric carcinoma cell clones expressing LMP2A of Epstein-Barr virus

International Journal of Molecular Medicine

Volumn 25, Issue 1, 2010, Pages 11-16

  Seo, Jung Seon ^a   Jun, Se Mo ^a   Kwon, Sang Wook ^a   Oh, Il Hoan ^a   Kim, Tai Gyu ^a   Lee, Suk Kyeong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Epstein Barr virus; Gastric carcinoma; Latent membrane protein 2A; Retroviral vector; Tumorigenesis

Indexed keywords

LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

AGAR MEDIUM; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CELL CLONING; CELL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSDUCTION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

AMINO ACID SEQUENCE; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CLONE CELLS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; STOMACH NEOPLASMS; VIRAL MATRIX PROTEINS;

EID: 70549097997     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000307     Document Type: Article

References (38)

1. Rickinson A: Epstein-Barr virus. Virus Res 82: 109-113, 2002.
2. Takada K, Shimizu N, Tanabe-Tochikura A and Kuroiwa Y: Pathogenic role of Epstein-Barr virus in human cancer. Intervirology 38: 214-220, 1995.
3. Young LS and Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22: 5108-5121, 2003.
4. Uozaki H and Fukayama M: Epstein-Barr virus and gastric carcinoma - viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1: 198-216, 2008.
5. Imai S, Koizumi S, Sugiura M, et al: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91: 9131-9135, 1994.
6. Fukayama M, Hayashi Y, Iwasaki Y, et al: Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71: 73-81, 1994.
7. zur Hausen A, van Grieken NC, Meijer GA, et al: Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 121: 612-618, 2001.
8. Nishikawa J, Imai S, Oda T, Kojima T, Okita K and Takada K: Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 73: 1286-1292, 1999.
9. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ and van den Brule AJ: Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 60: 2745-2748, 2000.
10. Sugiura M, Imai S, Tokunaga M, et al: Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74: 625-631, 1996.
11. Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB and Longnecker R: Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction. Infect Agents Dis 3: 128-136, 1994.
12. Portis T and Longnecker R: Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/ Akt pathway. Oncogene 23: 8619-8628, 2004.
13. Anderson LJ and Longnecker R: EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J Gen Virol 89: 1563-1568, 2008.
14. Swart R, Ruf IK, Sample J and Longnecker R: Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. J Virol 74: 10838-10845, 2000.
15. Fukuda M and Longnecker R: Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol 78: 1697-1705, 2004.
16. Kim OJ and Yates JL: Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. J Virol 67: 7634-7640, 1993.
17. Longnecker R, Miller CL, Miao XQ, Marchini A and Kieff E: The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66: 6461-6469, 1992.
18. Mancao C and Hammerschmidt W: Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110: 3715-3721, 2007.
19. Scholle F, Bendt KM and Raab-Traub N: Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74: 10681-10689, 2000.
20. Chen SY, Lu J, Shih YC and Tsai CH: Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76: 9556-9561, 2002.
21. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR and Thorley-Lawson DA: Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 79: 15430-15442, 2005.
22. Fukuda M and Longnecker R: Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/ Akt pathway. J Virol 81: 9299-9306, 2007.
23. Longan L and Longnecker R: Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J Gen Virol 81: 2245-2252, 2000.
24. Oh ST, Seo JS, Moon UY, et al: A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320: 330-336, 2004.
25. Park JG, Yang HK, Kim WH, et al: Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70: 443-449, 1997.
26. Barranco SC, Townsend CM Jr, Casartelli C, et al: Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43: 1703-1709, 1983.
27. Yoshiyama H, Imai S, Shimizu N and Takada K: Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71: 5688-5691, 1997.
28. Oh IH and Eaves CJ: Overexpression of a dominant negative form of STAT3 selectively impairs hematopoietic stem cell activity. Oncogene 21: 4778-4787, 2002.
29. Wigler M, Pellicer A, Silverstein S and Axel R: Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14: 725-731, 1978.
30. Swart R, Fruehling S and Longnecker R: Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction. Virology 263: 485-495, 1999.
31. Fruehling S, Swart R, Dolwick KM, Kremmer E and Longnecker R: Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol 72: 7796-7806, 1998.
32. Fruehling S and Longnecker R: The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235: 241-251, 1997.
33. Tanaka M, Kawaguchi Y, Yokofujita J, Takagi M, Eishi Y and Hirai K: Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes 19: 103-111, 1999.
34. zur Hausen H, Schulte-Holthausen H, Klein G, et al: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056-1058, 1970.
35. zur Hansen H, Diehl V, Wolf H, Schulte-Holthausen H and Schneider U: Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol 237: 189-190, 1972.
36. McTaggart S and Al-Rubeai M: Retroviral vectors for human gene delivery. Biotechnol Adv 20: 1-31, 2002.
37. Kim do N, Chae HS, Oh ST, et al: Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81: 1033-1036, 2007.
38. Pfeffer S, Zavolan M, Grasser FA, et al: Identification of virus-encoded microRNAs. Science 304: 734-736, 2004.